Austin TX 偏头痛临床试验
8项针对 偏头痛的研究正在 Austin及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Study of EVO756 in Adults With Migraine
招募中2 期
- FutureSearch Trials of Neurology, Austin
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
招募中3 期
- Dell Children's Medical Center, Austin
- Child Neurology Consultants of Austin - Central Austin, Austin
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
招募中3 期
- Dell Children's Medical Center, Austin
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
招募中3 期
- UT Health Austin at Dell Childrens Neurology Clinic /ID# 270577, Austin
Responding With Evidence and Access for Childhood Headaches
招募中
- Dell Children's Hospital-UT Health, Austin
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
招募中3 期
- UT Health Austin at Dell Children's Neurology Clinic /ID# 244266, Austin
- Austin Regional Clinic - ARC Four Points /ID# 276301, Austin
- Velocity Clinical Research, Austin /ID# 230557, Austin
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
招募中3 期
- FutureSearch Trials of Neurology, Austin
- Tekton Research, Austin
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
招募中2 期
- FutureSearch Trials, Austin
其他城市的 偏头痛试验
- Cincinnati, OH11 项研究
- Miami, FL8 项研究
- Philadelphia, PA8 项研究
- Concord, CA8 项研究
- Amherst, NY7 项研究
- Omaha, NE7 项研究
- Houston, TX7 项研究
- Washington, DC7 项研究
- Aurora, CO6 项研究
- Stamford, CT6 项研究
- San Diego, CA6 项研究
- Tampa, FL6 项研究
Austin的其他研究
- 非小细胞肺癌30 项研究
- 癌症（所有类型）20 项研究
- 肥胖症20 项研究
- 转移性癌症19 项研究
- 结直肠癌19 项研究
- 心力衰竭18 项研究
- 乳腺癌18 项研究
- 超重18 项研究
- 卵巢癌17 项研究
- 子宫内膜癌15 项研究
- 前列腺癌15 项研究
- 抑郁症14 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。